Adopting recommendations for implementing patient involvement in cancer research: a funder's approach
- PMID: 36859346
- PMCID: PMC9979457
- DOI: 10.1186/s40900-023-00410-z
Adopting recommendations for implementing patient involvement in cancer research: a funder's approach
Abstract
Background: The role of patients in cancer research is undergoing a significant evolution as all stakeholders seek to enhance the level of direct patient involvement in the design and development of clinical trials. However, there are significant hurdles that patients, patient advocates, laboratory researchers, clinical investigators, and funding institutions must overcome to implement relevant patient involvement in all aspects of biomedical research. By using innovative grant funding models, philanthropic organizations can lead the field in overcoming these challenges. Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a private philanthropy that funds academic research, has developed a novel approach for requiring and supporting partnerships among grantees and patients in designing and conducting research projects. This paper presents a reflective case study of efforts to advance the field of patient involvement in clinical research.
Methods: The decision to focus on patient involvement stems from an expressed focus area established by the RTFCCR board of directors. In conducting this work, RTFCCR partnered with Patvocates, a patient advocacy and engagement network, to create a set of guiding documents and resources aimed at public and private health research funders within various national, international, and therapeutic settings. This effort included a landscape assessment, interviews with experts, and an iterative development process.
Results: To date, RTFCCR has completed and disseminated three guiding documents, one for funders, one for grant applicants, and one for patient advocates. These resources have already generated three major ongoing initiatives at RTFCCR: (1) inclusion of these recommendations in the foundation's funding guidelines; patient input to prioritization of research focus areas; and in topic selection for calls for proposals; (2) direct involvement of patient experts in the grant review process; and (3) a commitment to support high impact clinical research projects in Low- and Middle-Income Countries. Moreover, the foundation has launched a partnership with the International Cancer Research Partnership, the global alliance of cancer research organizations.
Conclusion: By using its grantmaking function and developing standardized approaches for implementation of patient involvement, RTFCCR is seeking to advance patient-centric cancer clinical research. This approach will continue to develop as it is implemented and shared with partners throughout the world.
Keywords: Call for proposals; Clinical research; Focus areas; Funding guidelines; Grant making; Grant review process; Low- and middle-income countries; Patient directed trials; Patient involvement; Philanthropic funding.
Plain language summary
The Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a private philanthropy that funds academic research, has developed a novel approach for requiring and supporting partnerships among grantees (scientists) and patients in designing and conducting research projects.The decision to focus on patient involvement stems from an expressed focus area established by the RTFCCR board of directors. In conducting this work, RTFCCR partnered with Patvocates, a patient advocacy and engagement network. Patvocates conducted a landscape assessment, interviews with experts, and their collective experience as patient advocates. This work generated a set of guiding documents and resources. These resources are to help public and private health research funders to better understand current challenges and support scientists and patients through their funding mechanisms. Three guiding documents, one for funders, one for grant applicants, and one for patient advocates are now available for download at the RTFCCR website: https://www.risingtide-foundation.org/clinical-cancer-research/patient-engagement#start Delivering a paradigm change involves not only the introduction of additional requirements and rules, but also enhanced education of patients and investigators. By using its grantmaking function and developing standardized approaches for implementation of patient involvement, RTFCCR is seeking to advance patient-centric cancer clinical research.Development and implementation of consistent policies and procedures for the integration of the patients’ view in the design and review of research proposals is needed for funders as well as for research institutes, both public and private.
© 2023. The Author(s).
Conflict of interest statement
Richard Stephens is Co-Editor-in-Chief of this journal. He played no part in any editorial considerations or decisions for this paper. The other authors declare that they have no competing interests.
Figures
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
The NCI All Ireland Cancer Conference.Oncologist. 1999;4(4):275-277. Oncologist. 1999. PMID: 10545862
-
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072. JBI Database System Rev Implement Rep. 2015. PMID: 26447009
-
Patient leadership and partnerships accelerate therapies for SCN8A and other developmental and epileptic encephalopathies.Ther Adv Rare Dis. 2025 Feb 20;6:26330040241252449. doi: 10.1177/26330040241252449. eCollection 2025 Jan-Dec. Ther Adv Rare Dis. 2025. PMID: 39989508 Free PMC article. Review.
-
Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities.Front Public Health. 2023 May 4;11:1172557. doi: 10.3389/fpubh.2023.1172557. eCollection 2023. Front Public Health. 2023. PMID: 37213606 Free PMC article. Review.
Cited by
-
Strategies for meaningful patient and public involvement in neuro-oncological research.Neurooncol Pract. 2024 Jan 3;11(2):109-110. doi: 10.1093/nop/npad080. eCollection 2024 Apr. Neurooncol Pract. 2024. PMID: 38496919 Free PMC article. No abstract available.
-
Regional differences in experiences of patients with metastatic breast cancer in the Republic of Ireland and Northern Ireland: a comparative analysis (CTRIAL-IE 23-05).BMJ Open Qual. 2025 Jul 1;14(3):e003254. doi: 10.1136/bmjoq-2024-003254. BMJ Open Qual. 2025. PMID: 40592729 Free PMC article.
-
Advancing patient-centered research practices in a pragmatic patient-level randomized clinical trial: A thematic analysis of stakeholder engagement in Emergency Medicine Palliative Care Access (EMPallA).Res Involv Engagem. 2024 Jan 23;10(1):10. doi: 10.1186/s40900-023-00539-x. Res Involv Engagem. 2024. PMID: 38263088 Free PMC article.
-
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research.NPJ Breast Cancer. 2025 Jun 21;11(1):60. doi: 10.1038/s41523-025-00771-6. NPJ Breast Cancer. 2025. PMID: 40544177 Free PMC article.
-
Patient research partner involvement in rheumatology research: a systematic literature review informing the 2023 updated EULAR recommendations for the involvement of patient research partners.Ann Rheum Dis. 2024 Sep 30;83(10):1268-1277. doi: 10.1136/ard-2024-225567. Ann Rheum Dis. 2024. PMID: 38724076 Free PMC article.
References
-
- BMBF. United Against Cancer. Berlin: Bundesministerium für Bildung und Forschung. (2020). https://www.bmbf.de/SharedDocs/Downloads/en/210907-unite-against-cancer..... Accessed 14 Dec 2021.
-
- Culture and Process Change as a Priority for Patient Engagement in Medicines Development https://link.springer.com/content/pdf/10.1177/2168479016659104.pdf. Accessed 14 Dec 2021. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous